2014


To access this material please log in or register

Register Authorize
2014/№6

Renal dysfunction in ST-elevation myocardial infarction: risk factors; effect on prognosis

Karetnikova V. N.1, Evseeva M. V.1, Kalaeva V. V.2, Gruzdeva O. V.2, Kashtalap V. V.2, Shafranskaya K. S.2, Zykov M. V.2, Barbarash O. L.2
1 - State Budgetary Educational Institution of Higher Professional Education “Kemerovo State Medical Academy” of the RF Ministry of Health Care, Voroshilova 22a, Kemerovo 650029
2 - Federal State Budgetary Institution “Research Institute for Complex Issues of Cardiovascular Diseases” at the Siberian Branch of the Russian Academy of Medical Sciences, Sosnovy Bulvar 6, Kemerovo 650002

Keywords: ST-segment elevation myocardial infarction, renal dysfunction, prognosis


DOI: 10.18087/rhj.2014.6.2010

Background. Health care providers often disregard transient renal dysfunction (RD), the role of which in MI prognosis has been extensively discussed. On the other hand, the issue of impaired renal function results in less rational approach to secondary prevention in this group of patients. Evaluation of risk factors (RFs) for development of RD is particularly important for both prevention of these disorders and prediction of unfavorable cardiovascular outcomes in patients with MI. Aim. To determine RFs for development of RD and the effect of RD on in-hospital and remote (one and two years) prognosis in patients with ST-elevation MI (STEMI). Materials and methods. Participants of this registry study were 954 patients with ST-elevation acute coronary syndrome (ACS), including 620 (65 %) men. Mean age of the general sample was 63.4 (62.6–64.2). To calculate the glomerular filtration rate (GFR), the MDRD formula was used, which took into account the serum creatinine level measured on admission. Results. Based on GFR values, all patients were divided into two groups, with (n=351; 36.8 %) and without RD (n=603; 63.2 %). RD was defined as a decrease in GFR to lower than 60 ml / min / 1.73 m2. Monofactorial analysis showed that the presence of RD in the acute STEMI phase 3.3 times increased the risk for fatal outcome within the next year and 2.5 times within the next three years. The presence of DM increased the probability for RD 1.7 times, chronic kidney disease (CKD), arterial hypertension (AH), and Killip class II–IV acute HF (AHF) – 2.1–2.2 times; and multifocal atherosclerosis (MFA) – 4 times. Multifactorial logistic regression analysis determined a set of predictors influencing the development of RD: ageing by one year increased the probability of RD by 6.2 %; probability of MI-associated RD was lower for men than for women; and a higher Killip class of AHF increased the chance for RD 1.9 times. Conclusion. RD detected in the acute phase of STEMI influences the incidence of adverse outcomes in inpatient and remote (one and three years) postinfarction phases. Women older that 60 with Killip class II–IV AHF are at higher risk of RD in STEMI.
  1. Кобалава Ж. Д., Виллевальде С. В., Ефремовцева М. А., Моисеев В. С. Кардиоренальные взаимоотношения: современные представления. Кардиоваскулярная терапия и профилактика. 2010;4:4–11.
  2. Budoff MJ, Rader DJ, Reilly MP et al. Relationship of estimated GFR and coronary artery calcification in the (CRIC) Chronic Renal Insufficiency Cohort study. Am J Kidney Dis. 2011 Oct;58 (4):519–26.
  3. Щекочихин Д. Ю., Козловская Н. Л., Копылов Ф. Ю. Особен­ности формирования кардиоренального синдрома при декомпенсации хронической сердечной недостаточности. Нефрология и диализ. 2013;15 (1):59–64.
  4. Эрлих А. Д. Регистры острых коронарных синдромов – их виды, характеристики и место в клинической практике. Вестник РАМН. 2012;4:30–9.
  5. Levey A, Stevens AL, Schmid CH et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009 May 5;150 (9):604–12.
  6. Vanholder R, Massy Z, Argiles A et al. Chronic kidney disease as cause of cardiovascular morbidity and mortality. Nephrol Dial Transplant. 2005 Jun;20 (6):1048–56.
  7. Каретникова В. Н., Зыков М. В., Кашталап В. В. и др. Значение почечной дисфункции для госпитального прогноза больных инфарктом миокарда с подъемом сегмента ST. Сердце. 2013;12 (5):284–9.
  8. Смирнов А. В., Добронравов В. А., Каюков И. Г. Кардио­реналь­ный континуум патогенетические основы превентивной нефрологии. Нефрология. 2005;9 (3):7–15.
  9. Szummer K, Lundman P, Jacobson SH et al. Influence of renal function on the effects of early revascularization in non-ST-elevation myocardial infarction: data from the Swedish Web-System for Enhancement and Development of Evidence-Based Care in Heart Disease Evaluated According to Recommended Therapies (SWEDEHEART). Circulation. 2009 Sep 8;120 (10):851–8.
  10. Hanna EB, Chen AY, Roe MT, Saucedo JF. Characteristics and in-hospital outcomes of patients presenting with non-ST-segment elevation myocardial infarction found to have significant coronary artery disease on coronary angiography and managed medically: stratification according to renal function. Am Heart J. 2012 Jul;164 (1):52–7.
  11. McClellan WM, Hodgin E, Pastan S et al. A randomized evaluation of two health care quality improvement program (HCQIP) interventions to improve the adequacy of hemodialysis care of ESRD patients: feedback alone versus intensive intervention. J Am Soc Nephrol. 2004 Mar;15 (3):754–60.
  12. Levey AS, De Jong PE, Coresh J et al. The definition, classification, and prognosis of chronic kidney disease: a KDIGO Controversies Conference report. Kidney Int. 2011 Jul;80 (1):17–28.
  13. Anavekar NS, McMurray JJ, Velazquez EJ et al. Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction. N Engl J Med. 2004 Sep 23;351 (13):1285–95.
  14. Shroff GR, Herzog CA. Acute myocardial infarction in patients with chronic kidney disease: how are the most vulnerable patients doing? Kidney Int. 2013 Aug;84 (2):230–3.
  15. Bittencourt MS, Hulten EA, Abbara S et al. Renal Dysfunction Predicts the Presence and Extent of Coronary Artery Disease on Coronary CT Angiography. Circulation. 2012;126: A11565.
  16. Dan K, Miyoshi T, Nakamura K et al. Impact of Renal Dysfunction on Left Main Coronary Artery Disease in Patients with Stable Angina Pectoris. Circulation. 2011;124: A10001
  17. Onoue K, Uemura S, Takeda Y et al. Reduction of circulating soluble fms-like tyrosine kinase-1 plays a significant role in renal dysfunction – associated aggravation of atherosclerosis. Circulation. 2009 Dec;120 (24):2470–7.
  18. Lu J, Deshmukh A, Wang X et al. Acute Myocardial Ischemia Results in Renal Dysfunction via Systemic and Local Inflammation and Oxidant Stress, and LOX-1 Abrogation Attenuates This Phenomenon. Circulation. 2011;124: A9519.
  19. Nakatani D, Sakata Y, Suna S et al. Independent and Combined Effect of Heart Failure and Renal Dysfunction on One-year Mortality in Patients with Acute Myocardial Infarction. Circulation. 2012;126: A18994.
  20. Breidthardt T, Mebazaa A, Mueller CE. Predicting progression in nondiabetic kidney disease: the importance of cardiorenal interactions. Kidney Int. 2009 Feb;75 (3):253–5.
  21. Yamagata K, Ishida K, Sairenchi T et al. Risk factors for chronic kidney disease in a community-based population: a 10‑year follow-up study. Kidney Int. 2007 Jan;71 (2):159–66.
  22. Taal MW, Brenner BM. Predicting initiation and progression of chronic kidney disease: Developing renal risk scores. Kidney Int. 2006 Nov;70 (10):1694–705.
Karetnikova V. N., Evseeva M. V., Kalaeva V. V. et al. Renal dysfunction in ST-elevation myocardial infarction: risk factors; effect on prognosis. Russian Heart Journal. 2014;13 (6):339–346.

To access this material please log in or register

Register Authorize
Ru En